 Intralesional interferon therapy basal cell carcinoma clinical trial patients medical centers IU placebo biopsy-proved noduloulcerative superficial basal cell times weeks cumulative dose IU Efficacy treatment weeks examination biopsy specimens cure lesions interferon-treated patients placebo-treated patients treatment course follow-up initial inflammatory response treatment diminished erythema improvement overall appearance decrease size lesions Side effects treatment flu-like symptoms mild transient interferon-treated group patients interferon-treated group therapy side effects year initiation therapy interferon recipients placebo tumor free Noduloulcerative superficial lesions responsive treatment interferon patients noduloulcerative superficial basal cell carcinomas intralesional interferon alternative effective treatment